Ticker Details
Acumen Pharmaceuticals, Inc.
IPO Date:	July 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$150.22M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 3.76%
Avg Daily Range (30 D):	$0.10 | 4.40%
Avg Daily Range (90 D):	$0.09 | 4.37%

Institutional Daily Volume
Avg Daily Volume:	.34M
Avg Daily Volume (30 D):	.78M
Avg Daily Volume (90 D):	.42M

Trade Size
Avg Trade Size (Sh.):	116
Avg Trade Size (Sh.) (30 D):	144
Avg Trade Size (Sh.) (90 D):	155

Institutional Trades
Total Institutional Trades:	60
Avg Institutional Trade:	$2.13M
Avg Institutional Trade (30 D):	$1M
Avg Institutional Trade (90 D):	$1M
Avg Institutional Trade Volume:	.39M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.31M
Avg Closing Trade (30 D):	$3.8M
Avg Closing Trade (90 D):	$3.8M
Avg Closing Volume:	640.1K

News

Nov 5, 2025 @ 9:00 PM Acumen Pharmaceuticals to Report Third Quarter 202... Source: Acumen Pharmaceuticals

Aug 26, 2025 @ 8:00 PM Acumen Pharmaceuticals to Participate in Upcoming ... Source: Acumen Pharmaceuticals

Aug 5, 2025 @ 8:00 PM Acumen Pharmaceuticals to Report Second Quarter 20... Source: Acumen Pharmaceuticals

Jul 10, 2025 @ 12:00 PM Acumen Pharmaceuticals to Present Studies on Cost ... Source: Acumen Pharmaceuticals

May 7, 2025 @ 8:00 PM Acumen Pharmaceuticals to Participate in the Bank ... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.22	$-.44	$-.68
Diluted EPS	$-2.22	$-.44	$-.68
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-133.35M	$-26.45M	$-40.95M
Operating Income / Loss	$-138.23M	$-26.51M	$-41.75M
Cost of Revenue
Net Cash Flow	$13.64M	$10.02M	$6.65M
PE Ratio